Study for endometrial receptivity assessed by ultrasound in combination with VEGF and integrin avß3 in women with PCOS

Study for endometrial receptivity in women with polycystic ovary syndrome

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023423

Enrollment

Unknown

Registered

2019-05-27

Start date

2019-06-01

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

PCOS-1:natural periodic, no intervention

PCOS-2:clomiphene citrate

PCOS-3:letrozole

healthy control group :no intervention

Eligibility

Sex/Gender

Female

Age

22 Years to 40 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria of polycystic ovary syndrome we used was modified Rotterdam criteria(2003):(1) rare ovulation or no ovulation; (2) clinical or biochemical manifestations of hyperandrogenemia; (3) polycystic ovarian changes, three in line with two can be diagnosed as polycystic ovarian syndrome.

Exclusion criteria

Exclusion criteria: Women were excluded if they had congenital adrenal hyperplasia, gynecological surgery, thyroid disease,chronic diseases, autoimmune disease, single or bilateral fallopian tube obstruction, male with abnormal semen and any other acute illness.

Design outcomes

Primary

Measure	Time frame
ultrasonographic markers of endometrial receptivity;VEGF, integrin avß;	—

Countries

China

Contacts

Public ContactWang Li

The First Affiliated Hospital of Xi'an Jiaotong University

wangli811125@163.com+86 15332309306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026